menu search

Ibrx stock news: contact robbins llp for information regarding immunitybio, inc. class action

SAN DIEGO, July 18, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entit...

July 18, 2023, 10:31 pm

Class action alert: the law offices of vincent wong remind immunitybio investors of a lead plaintiff deadline of august 29, 2023

NEW YORK, July 18, 2023 (GLOBE NEWSWIRE) — Attention ImmunityBio, Inc. (“ImmunityBio”) (NASDAQ: IBRX) shareholders: The Law Offices of Vincent W...

July 18, 2023, 9:45 am

Rosen, a longstanding law firm, encourages immunitybio, inc. investors with losses to secure counsel before important deadline in securities class action – ibrx

NEW YORK, July 17, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ImmunityBio, ...

July 18, 2023, 1:36 am

Bragar eagel & squire, p.c. reminds investors that class action lawsuits have been filed against arrow financial, immunitybio, seagate, and baxter and encourages investors to contact the firm

NEW YORK, July 16, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that ...

July 17, 2023, 12:58 am

Gainey mckenna & egleston announces a class action lawsuit has been filed against immunitybio, inc. (ibrx)

NEW YORK, July 05, 2023 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United S...

July 5, 2023, 10:18 pm

Immunitybio, inc. shareholder alert: bernstein liebhard llp announces that a securities class action lawsuit has been filed against immunitybio, inc. (nasdaq: ibrx)

NEW YORK, July 05, 2023 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP: Do you, or did you, own shares of ImmunityBio, Inc. (NASDAQ: IBRX)? Did you purch...

July 5, 2023, 8:30 pm

Immunitybio, inc. (ibrx) shareholder notice: robbins llp reminds investors of class action against immunitybio, inc.

SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entit...

July 5, 2023, 4:19 pm

Calling all immunitybio, inc. (ibrx) investors: contact bronstein, gewirtz & grossman, llc today!

NEW YORK, July 03, 2023 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies i...

July 3, 2023, 8:00 pm

Ibrx alert: hagens berman, national trial attorneys, encourages immunitybio (ibrx) investors with substantial losses to contact firm’s attorneys, securities fraud class action filed

SAN FRANCISCO, July 02, 2023 (GLOBE NEWSWIRE) — Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to su...

July 2, 2023, 3:25 pm

Pomerantz law firm announces the filing of a class action against immunitybio, inc. and certain officers – ibrx

NEW YORK, June 30, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against ImmunityBio, Inc. (“Immunity...

June 30, 2023, 11:10 pm

immunitybio can recover from bla dip

The FDA rejected the Anktiva marketing application last month. Since the troubles lie with an outside organization, the company has no control over th...

June 20, 2023, 12:48 am

Investigation of immunitybio, inc. (ibrx) announced by holzer & holzer, llc

ATLANTA, May 18, 2023 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether ImmunityBio, Inc. (“ImmunityBio,” or the “Company”) (...

May 18, 2023, 9:53 pm

Immunitybio: amidst difficulty is your opportunity

Being an extremely volatile stock, ImmunityBio, Inc. is not for all investors. Nevertheless, there are tremendous opportunities in ...

May 17, 2023, 11:23 am

Fda rejects immunitybio's (ibrx) bladder cancer therapy filing

FDA rejects ImmunityBio's (IBRX) filing seeking approval of Anktiva (N-803) as a combo-therapy in bladder cancer indication, citing deficiencies in an...

May 12, 2023, 12:57 pm

Immunitybio: anktiva rejection heightens financial urgency

immunitybio stock dropped over 50% after the FDA issued a CRL for Anktiva, their lead product for treat...

May 12, 2023, 5:20 am

Immunitybio: kaplan fox investigates immunitybio

NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Immunity...

May 11, 2023, 11:56 pm

Why is immunitybio (ibrx) stock down 54% today?

immunitybio (NASDAQ: IBRX ) stock is falling on Thursday after the company got a complete response lett...

May 11, 2023, 11:05 am

2 pharma stocks in focus on fda buzz

immunitybio Inc (NASDAQ:IBRX) stock is crumbling today, down 52.1% at $2.98 at last glance, and earlie...

May 11, 2023, 10:55 am

immunitybio in dramatic selloff as fda puts bladder cancer treatment on hold

immunitybio Inc shares were sinking fast on Thursday morning after receiving notice from the US Food an...

May 11, 2023, 10:15 am

immunitybio stock loses more than half its value after disclosing fda can't approve the bla for its cancer treatment in its present form

Shares of immunitybio Inc. IBRX plummeted 53.7% toward a record one-day selloff in premarket trading Th...

May 11, 2023, 9:16 am


Search within

Pages Search Results: